Quantification of overall tumor burden revealed a significant decrease of the tumor areas in the lungs of Aiffl/yKrasG12D mice compared to Aif+/yKrasG12D controls at all time-points analyzed (Fig. 1b, c). The gene discussed is AIFM1; the disease is neoplasm.